Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Mar;54(3):254–264. doi: 10.1136/thx.54.3.254

Lymphangioleiomyomatosis: clinical features, management and basic mechanisms

S Johnson 1
PMCID: PMC1745441  PMID: 10325903

Full Text

The Full Text of this article is available as a PDF (249.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson D., Heinrichs W. L., Raybin D. M., Raffin T. A. Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone. Am Rev Respir Dis. 1985 Oct;132(4):916–921. doi: 10.1164/arrd.1985.132.4.916. [DOI] [PubMed] [Google Scholar]
  2. Adema G. J., de Boer A. J., Vogel A. M., Loenen W. A., Figdor C. G. Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem. 1994 Aug 5;269(31):20126–20133. [PubMed] [Google Scholar]
  3. Basu T. N., Gutmann D. H., Fletcher J. A., Glover T. W., Collins F. S., Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 1992 Apr 23;356(6371):713–715. doi: 10.1038/356713a0. [DOI] [PubMed] [Google Scholar]
  4. Berger U., Khaghani A., Pomerance A., Yacoub M. H., Coombes R. C. Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study. Am J Clin Pathol. 1990 May;93(5):609–614. doi: 10.1093/ajcp/93.5.609. [DOI] [PubMed] [Google Scholar]
  5. Bernstein S. M., Newell J. D., Jr, Adamczyk D., Mortenson R. L., King T. E., Jr, Lynch D. A. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2138–2143. doi: 10.1164/ajrccm.152.6.8520787. [DOI] [PubMed] [Google Scholar]
  6. Bittmann I., Dose T. B., Müller C., Dienemann H., Vogelmeier C., Löhrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol. 1997 Dec;28(12):1420–1423. doi: 10.1016/s0046-8177(97)90233-1. [DOI] [PubMed] [Google Scholar]
  7. Boehler A., Speich R., Russi E. W., Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med. 1996 Oct 24;335(17):1275–1280. doi: 10.1056/NEJM199610243351704. [DOI] [PubMed] [Google Scholar]
  8. Bonetti F., Chiodera P. L., Pea M., Martignoni G., Bosi F., Zamboni G., Mariuzzi G. M. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol. 1993 Nov;17(11):1092–1102. doi: 10.1097/00000478-199311000-00002. [DOI] [PubMed] [Google Scholar]
  9. Bonetti F., Pea M., Martignoni G., Doglioni C., Zamboni G., Capelli P., Rimondi P., Andrion A. Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology. 1994 Jul;26(3):230–236. doi: 10.1080/00313029400169561. [DOI] [PubMed] [Google Scholar]
  10. Bosniak M. A. Angiomyolipoma (hamartoma) of the kidney: a preoperative diagnosis is possible in virtually every case. Urol Radiol. 1981;3(3):135–142. doi: 10.1007/BF02938781. [DOI] [PubMed] [Google Scholar]
  11. Brauner M. W., Grenier P., Tijani K., Battesti J. P., Valeyre D. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology. 1997 Aug;204(2):497–502. doi: 10.1148/radiology.204.2.9240543. [DOI] [PubMed] [Google Scholar]
  12. Brentani M. M., Carvalho C. R., Saldiva P. H., Pacheco M. M., Oshima C. T. Steroid receptors in pulmonary lymphangiomyomatosis. Chest. 1984 Jan;85(1):96–99. doi: 10.1378/chest.85.1.96. [DOI] [PubMed] [Google Scholar]
  13. Brock E. T., Votto J. J. Lymphangioleiomyomatosis: treatment with hormonal manipulation. N Y State J Med. 1986 Oct;86(10):533–536. [PubMed] [Google Scholar]
  14. Brunelli A., Catalini G., Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int J Gynaecol Obstet. 1996 Mar;52(3):289–290. doi: 10.1016/0020-7292(95)02619-3. [DOI] [PubMed] [Google Scholar]
  15. Bucci C., Parton R. G., Mather I. H., Stunnenberg H., Simons K., Hoflack B., Zerial M. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 1992 Sep 4;70(5):715–728. doi: 10.1016/0092-8674(92)90306-w. [DOI] [PubMed] [Google Scholar]
  16. Burger C. D., Hyatt R. E., Staats B. A. Pulmonary mechanics in lymphangioleiomyomatosis. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1030–1033. doi: 10.1164/ajrccm/143.5_Pt_1.1030. [DOI] [PubMed] [Google Scholar]
  17. Calvo E., Amarillas L., Mateos M. A., Orradre J. L., Gilsanz G., Alvarez-Sala J. L., Espinos D. Lymphangioleiomyomatosis, chylous ascites, and diet. Dig Dis Sci. 1996 Mar;41(3):591–593. doi: 10.1007/BF02282346. [DOI] [PubMed] [Google Scholar]
  18. Camaggi C. M., Strocchi E., Giovannini M., Angelelli B., Costanti B., Zebini E., Ferrari P., Pannuti F. Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients. Cancer Chemother Pharmacol. 1983;11(1):19–22. doi: 10.1007/BF00257410. [DOI] [PubMed] [Google Scholar]
  19. Castro M., Shepherd C. W., Gomez M. R., Lie J. T., Ryu J. H. Pulmonary tuberous sclerosis. Chest. 1995 Jan;107(1):189–195. doi: 10.1378/chest.107.1.189. [DOI] [PubMed] [Google Scholar]
  20. Chan J. K., Tsang W. Y., Pau M. Y., Tang M. C., Pang S. W., Fletcher C. D. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. Histopathology. 1993 May;22(5):445–455. doi: 10.1111/j.1365-2559.1993.tb00158.x. [DOI] [PubMed] [Google Scholar]
  21. Chiappetta G., Avantaggiato V., Visconti R., Fedele M., Battista S., Trapasso F., Merciai B. M., Fidanza V., Giancotti V., Santoro M. High level expression of the HMGI (Y) gene during embryonic development. Oncogene. 1996 Dec 5;13(11):2439–2446. [PubMed] [Google Scholar]
  22. Conrad S., Wagner B., Hamper K., Henke R. P. Nierenkarzinom und Angiomyolipom bei Lymphangiomyomatose. Urologe A. 1994 Jan;33(1):76–79. [PubMed] [Google Scholar]
  23. Corrin B., Liebow A. A., Friedman P. J. Pulmonary lymphangiomyomatosis. A review. Am J Pathol. 1975 May;79(2):348–382. [PMC free article] [PubMed] [Google Scholar]
  24. Cutler G. B., Jr, Hoffman A. R., Swerdloff R. S., Santen R. J., Meldrum D. R., Comite F. NIH conference. Therapeutic applications of luteinizing-hormone-releasing hormone and its analogs. Ann Intern Med. 1985 May;102(5):643–657. doi: 10.7326/0003-4819-102-5-643. [DOI] [PubMed] [Google Scholar]
  25. Eliasson A. H., Phillips Y. Y., Tenholder M. F. Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest. 1989 Dec;96(6):1352–1355. doi: 10.1378/chest.96.6.1352. [DOI] [PubMed] [Google Scholar]
  26. Ernst J. C., Sohaey R., Cary J. M. Pelvic lymphangioleiomyomatosis. Atypical precursor to pulmonary disease. Chest. 1994 Oct;106(4):1267–1269. doi: 10.1378/chest.106.4.1267. [DOI] [PubMed] [Google Scholar]
  27. Flieder D. B., Travis W. D. Clear cell "sugar" tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am J Surg Pathol. 1997 Oct;21(10):1242–1247. doi: 10.1097/00000478-199710000-00017. [DOI] [PubMed] [Google Scholar]
  28. Fukuda Y., Kawamoto M., Yamamoto A., Ishizaki M., Basset F., Masugi Y. Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis. Hum Pathol. 1990 Dec;21(12):1252–1261. doi: 10.1016/s0046-8177(06)80039-0. [DOI] [PubMed] [Google Scholar]
  29. Green A. J., Johnson P. H., Yates J. R. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet. 1994 Oct;3(10):1833–1834. doi: 10.1093/hmg/3.10.1833. [DOI] [PubMed] [Google Scholar]
  30. Green A. J., Smith M., Yates J. R. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet. 1994 Feb;6(2):193–196. doi: 10.1038/ng0294-193. [DOI] [PubMed] [Google Scholar]
  31. Hammadeh M. Y., Thomas K., Philp T., Singh M. Renal cell carcinoma containing fat mimicking angiomyolipoma: demonstration with CT scan and histopathology. Eur Radiol. 1998;8(2):228–229. doi: 10.1007/s003300050367. [DOI] [PubMed] [Google Scholar]
  32. Han Y. M., Kim J. K., Roh B. S., Song H. Y., Lee J. M., Lee Y. H., Lee S. Y., Chung G. H., Kim C. S., Sohn M. H. Renal angiomyolipoma: selective arterial embolization--effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology. 1997 Jul;204(1):65–70. doi: 10.1148/radiology.204.1.9205224. [DOI] [PubMed] [Google Scholar]
  33. Hayashi T., Fleming M. V., Stetler-Stevenson W. G., Liotta L. A., Moss J., Ferrans V. J., Travis W. D. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol. 1997 Sep;28(9):1071–1078. doi: 10.1016/s0046-8177(97)90061-7. [DOI] [PubMed] [Google Scholar]
  34. Henske E. P., Neumann H. P., Scheithauer B. W., Herbst E. W., Short M. P., Kwiatkowski D. J. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer. 1995 Aug;13(4):295–298. doi: 10.1002/gcc.2870130411. [DOI] [PubMed] [Google Scholar]
  35. Hess J. L. Chromosomal translocations in benign tumors: the HMGI proteins. Am J Clin Pathol. 1998 Mar;109(3):251–261. doi: 10.1093/ajcp/109.3.251. [DOI] [PubMed] [Google Scholar]
  36. Hesselius I., Johansson E. D. Medroxyprogesterone acetate (MPA) plasma levels after oral and intramuscular administration in a long-term study. Acta Obstet Gynecol Scand Suppl. 1981;101:65–70. doi: 10.3109/00016348109157815. [DOI] [PubMed] [Google Scholar]
  37. Hoon V., Thung S. N., Kaneko M., Unger P. D. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med. 1994 Jul;118(7):732–734. [PubMed] [Google Scholar]
  38. Hughes E., Hodder R. V. Pulmonary lymphangiomyomatosis complicating pregnancy. A case report. J Reprod Med. 1987 Jul;32(7):553–557. [PubMed] [Google Scholar]
  39. Itoh T., Mochizuki M., Kumazaki S., Ishihara T., Fukayama M. Cystic pulmonary metastases of endometrial stromal sarcoma of the uterus, mimicking lymphangiomyomatosis: a case report with immunohistochemistry of HMB45. Pathol Int. 1997 Oct;47(10):725–729. doi: 10.1111/j.1440-1827.1997.tb04449.x. [DOI] [PubMed] [Google Scholar]
  40. Jin F., Wienecke R., Xiao G. H., Maize J. C., Jr, DeClue J. E., Yeung R. S. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9154–9159. doi: 10.1073/pnas.93.17.9154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Johnson S. R., Knox A. J. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol Sci. 1997 Aug;18(8):288–292. doi: 10.1016/s0165-6147(97)01092-4. [DOI] [PubMed] [Google Scholar]
  42. Kalassian K. G., Doyle R., Kao P., Ruoss S., Raffin T. A. Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med. 1997 Apr;155(4):1183–1186. doi: 10.1164/ajrccm.155.4.9105053. [DOI] [PubMed] [Google Scholar]
  43. Kennelly M. J., Grossman H. B., Cho K. J. Outcome analysis of 42 cases of renal angiomyolipoma. J Urol. 1994 Dec;152(6 Pt 1):1988–1991. doi: 10.1016/s0022-5347(17)32286-3. [DOI] [PubMed] [Google Scholar]
  44. Kimura N., Watanabe M., Date F., Kitamoto T., Kumura I., Horii A., Nagura H. HMB-45 and tuberin in hamartomas associated with tuberous sclerosis. Mod Pathol. 1997 Sep;10(9):952–959. [PubMed] [Google Scholar]
  45. Kitaichi M., Nishimura K., Itoh H., Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):527–533. doi: 10.1164/ajrccm.151.2.7842216. [DOI] [PubMed] [Google Scholar]
  46. Kitayama H., Sugimoto Y., Matsuzaki T., Ikawa Y., Noda M. A ras-related gene with transformation suppressor activity. Cell. 1989 Jan 13;56(1):77–84. doi: 10.1016/0092-8674(89)90985-9. [DOI] [PubMed] [Google Scholar]
  47. Klein M., Krieger O., Ruckser R., Rosen A., Waldner R., Preis P., Beck A. Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report. Arch Gynecol Obstet. 1992;252(2):99–102. doi: 10.1007/BF02389635. [DOI] [PubMed] [Google Scholar]
  48. Lemaitre L., Robert Y., Dubrulle F., Claudon M., Duhamel A., Danjou P., Mazeman E. Renal angiomyolipoma: growth followed up with CT and/or US. Radiology. 1995 Dec;197(3):598–602. doi: 10.1148/radiology.197.3.7480725. [DOI] [PubMed] [Google Scholar]
  49. Logan R. F., Fawcett I. W. Oophorectomy for pulmonary lymphangioleiomyomatosis: a case report. Br J Dis Chest. 1985 Jan;79(1):98–100. doi: 10.1016/0007-0971(85)90013-0. [DOI] [PubMed] [Google Scholar]
  50. Maziak D. E., Kesten S., Rappaport D. C., Maurer J. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J. 1996 Mar;9(3):402–405. doi: 10.1183/09031936.96.09030402. [DOI] [PubMed] [Google Scholar]
  51. McKay S., de Jongste J. C., Saxena P. R., Sharma H. S. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol. 1998 Jun;18(6):823–833. doi: 10.1165/ajrcmb.18.6.2924. [DOI] [PubMed] [Google Scholar]
  52. Müller N. L., Chiles C., Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology. 1990 May;175(2):335–339. doi: 10.1148/radiology.175.2.2326457. [DOI] [PubMed] [Google Scholar]
  53. Nine J. S., Yousem S. A., Paradis I. L., Keenan R., Griffith B. P. Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant. 1994 Jul-Aug;13(4):714–719. [PubMed] [Google Scholar]
  54. O'Brien J. D., Lium J. H., Parosa J. F., Deyoung B. R., Wick M. R., Trulock E. P. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med. 1995 Jun;151(6):2033–2036. doi: 10.1164/ajrccm.151.6.7767554. [DOI] [PubMed] [Google Scholar]
  55. Pea M., Bonetti F., Zamboni G., Martignoni G., Riva M., Colombari R., Mombello A., Bonzanini M., Scarpa A., Ghimenton C. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology. 1991 Jul;23(3):185–188. doi: 10.3109/00313029109063563. [DOI] [PubMed] [Google Scholar]
  56. Peccatori I., Pitingolo F., Battini G., Meroni M., Giordano F., Guarino M., Maschio A. D., Vanzulli A., Sessa A. Pulmonary lymphangioleiomyomatosis and renal papillary cancer: incomplete expression of tuberous sclerosis? Nephrol Dial Transplant. 1997 Dec;12(12):2740–2743. doi: 10.1093/ndt/12.12.2740. [DOI] [PubMed] [Google Scholar]
  57. Peyrol S., Gindre D., Cordier J. F., Loire R., Grimaud J. A. Characterization of the smooth muscle cell infiltrate and associated connective matrix of lymphangiomyomatosis. Immunohistochemical and ultrastructural study of two cases. J Pathol. 1992 Dec;168(4):387–395. doi: 10.1002/path.1711680409. [DOI] [PubMed] [Google Scholar]
  58. Popper H. H., Gamperl R., Pongratz M. G., Kullnig P., Jüttner-Smolle F. M., Pfragner R. Chromosome typing in lymphangioleiomyomatosis of the lung with and without tuberous sclerosis. Eur Respir J. 1993 May;6(5):753–759. [PubMed] [Google Scholar]
  59. Roach E. S., Smith M., Huttenlocher P., Bhat M., Alcorn D., Hawley L. Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol. 1992 Apr;7(2):221–224. doi: 10.1177/088307389200700219. [DOI] [PubMed] [Google Scholar]
  60. Rossi G. A., Balbi B., Oddera S., Lantero S., Ravazzoni C. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis. Am Rev Respir Dis. 1991 Jan;143(1):174–176. doi: 10.1164/ajrccm/143.1.174. [DOI] [PubMed] [Google Scholar]
  61. Sawicka E. H., Morris A. J. A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy. Br J Dis Chest. 1985 Oct;79(4):400–406. doi: 10.1016/0007-0971(85)90077-4. [DOI] [PubMed] [Google Scholar]
  62. Shen A., Iseman M. D., Waldron J. A., King T. E. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest. 1987 May;91(5):782–785. doi: 10.1378/chest.91.5.782. [DOI] [PubMed] [Google Scholar]
  63. Sherrier R. H., Chiles C., Roggli V. Pulmonary lymphangioleiomyomatosis: CT findings. AJR Am J Roentgenol. 1989 Nov;153(5):937–940. doi: 10.2214/ajr.153.5.937. [DOI] [PubMed] [Google Scholar]
  64. Silverstein E. F., Ellis K., Wolff M., Jaretzki A., 3rd Pulmonary lymphangiomyomatosis. Am J Roentgenol Radium Ther Nucl Med. 1974 Apr;120(4):832–850. doi: 10.2214/ajr.120.4.832. [DOI] [PubMed] [Google Scholar]
  65. Smolarek T. A., Wessner L. L., McCormack F. X., Mylet J. C., Menon A. G., Henske E. P. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet. 1998 Apr;62(4):810–815. doi: 10.1086/301804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Soucek T., Pusch O., Wienecke R., DeClue J. E., Hengstschläger M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem. 1997 Nov 14;272(46):29301–29308. doi: 10.1074/jbc.272.46.29301. [DOI] [PubMed] [Google Scholar]
  67. Steiner M. S., Goldman S. M., Fishman E. K., Marshall F. F. The natural history of renal angiomyolipoma. J Urol. 1993 Dec;150(6):1782–1786. doi: 10.1016/s0022-5347(17)35895-0. [DOI] [PubMed] [Google Scholar]
  68. Stovin P. G., Lum L. C., Flower C. D., Darke C. S., Beeley M. The lungs in lymphangiomyomatosis and in tuberous sclerosis. Thorax. 1975 Oct;30(5):497–509. doi: 10.1136/thx.30.5.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Tanaka H., Imada A., Morikawa T., Shibusa T., Satoh M., Sekine K., Abe S. Diagnosis of pulmonary lymphangioleiomyomatosis by HMB45 in surgically treated spontaneous pneumothorax. Eur Respir J. 1995 Nov;8(11):1879–1882. doi: 10.1183/09031936.95.08111879. [DOI] [PubMed] [Google Scholar]
  70. Taylor J. R., Ryu J., Colby T. V., Raffin T. A. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med. 1990 Nov 1;323(18):1254–1260. doi: 10.1056/NEJM199011013231807. [DOI] [PubMed] [Google Scholar]
  71. Usuki J., Horiba K., Chu S. C., Moss J., Ferrans V. J. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status. Arch Pathol Lab Med. 1998 Oct;122(10):895–902. [PubMed] [Google Scholar]
  72. Valensi Q. J. Pulmonary lymphangiomyoma, a probable forme frust of tuberous sclerosis. A case report and survey of the literature. Am Rev Respir Dis. 1973 Dec;108(6):1411–1415. doi: 10.1164/arrd.1973.108.6.1411. [DOI] [PubMed] [Google Scholar]
  73. Viskum K. Pulmonary lymphangioleiomyomatosis. Monaldi Arch Chest Dis. 1993;48(3):233–236. [PubMed] [Google Scholar]
  74. Vossler M. R., Yao H., York R. D., Pan M. G., Rim C. S., Stork P. J. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 1997 Apr 4;89(1):73–82. doi: 10.1016/s0092-8674(00)80184-1. [DOI] [PubMed] [Google Scholar]
  75. Vrtel R., Verhoef S., Bouman K., Maheshwar M. M., Nellist M., van Essen A. J., Bakker P. L., Hermans C. J., Bink-Boelkens M. T., van Elburg R. M. Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex. J Med Genet. 1996 Jan;33(1):47–51. doi: 10.1136/jmg.33.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Wahedna I., Cooper S., Williams J., Paterson I. C., Britton J. R., Tattersfield A. E. Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study. Thorax. 1994 Sep;49(9):910–914. doi: 10.1136/thx.49.9.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Warren S. E., Lee D., Martin V., Messink W. Pulmonary lymphangiomyomatosis causing bilateral pneumothorax during pregnancy. Ann Thorac Surg. 1993 Apr;55(4):998–1000. doi: 10.1016/0003-4975(93)90135-5. [DOI] [PubMed] [Google Scholar]
  78. Wienecke R., König A., DeClue J. E. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem. 1995 Jul 7;270(27):16409–16414. doi: 10.1074/jbc.270.27.16409. [DOI] [PubMed] [Google Scholar]
  79. Williams A. J., Powell W. L., Collins T., Morton C. C. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am J Pathol. 1997 Mar;150(3):911–918. [PMC free article] [PubMed] [Google Scholar]
  80. Wilson P. J., Ramesh V., Kristiansen A., Bove C., Jozwiak S., Kwiatkowski D. J., Short M. P., Haines J. L. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum Mol Genet. 1996 Feb;5(2):249–256. doi: 10.1093/hmg/5.2.249. [DOI] [PubMed] [Google Scholar]
  81. Wolff M. Lymphangiomyoma: clinicopathologic study and ultrastructural confirmation of its histogenesis. Cancer. 1973 Apr;31(4):988–1007. doi: 10.1002/1097-0142(197304)31:4<988::aid-cncr2820310433>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  82. Xiao G. H., Shoarinejad F., Jin F., Golemis E. A., Yeung R. S. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem. 1997 Mar 7;272(10):6097–6100. doi: 10.1074/jbc.272.10.6097. [DOI] [PubMed] [Google Scholar]
  83. Xiao S., Lux M. L., Reeves R., Hudson T. J., Fletcher J. A. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol. 1997 Mar;150(3):901–910. [PMC free article] [PubMed] [Google Scholar]
  84. Yoshida Y., Kawata M., Miura Y., Musha T., Sasaki T., Kikuchi A., Takai Y. Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol. 1992 Aug;12(8):3407–3414. doi: 10.1128/mcb.12.8.3407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. van Baal J. G., Smits N. J., Keeman J. N., Lindhout D., Verhoef S. The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol. 1994 Jul;152(1):35–38. doi: 10.1016/s0022-5347(17)32809-4. [DOI] [PubMed] [Google Scholar]
  86. van Milligen de Wit A. W., Meilof-Planteydt M. N. Successful treatment of pulmonary lymphangioleiomyomatosis with oophorectomy and medroxyprogesterone-acetate: report of a case and brief review of the literature. Neth J Med. 1990 Jun;36(5-6):246–251. [PubMed] [Google Scholar]
  87. van Slegtenhorst M., Nellist M., Nagelkerken B., Cheadle J., Snell R., van den Ouweland A., Reuser A., Sampson J., Halley D., van der Sluijs P. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet. 1998 Jun;7(6):1053–1057. doi: 10.1093/hmg/7.6.1053. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES